Global Molecular Diagnostics Market Trend and Development Strategy Analysis 2023-2029
Market Analysis and Insights: Global Molecular Diagnostics Market
The global Molecular Diagnostics market size in 2022 is 20100.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 13.30% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Molecular Diagnostics market include F. Hoffmann-La Roche Ltd(Switzerland), Hologic, Inc., (U.S.), bioMérieux (France), Abbott (U.S.), and QIAGEN (Netherlands). The share of the top 3 players in the Molecular Diagnostics market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Molecular Diagnostics market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Reagents and Kits accounted for XX% of Molecular Diagnostics market in 2022. Instruments share of XX%.
Hospital accounted for XX% of the Molecular Diagnostics market in 2022. Clinical Laboratories accounts for XX%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics market.
Global Molecular Diagnostics Scope and Market Size
Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource.
The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Molecular Diagnostics industry is considered in the report, covering the dynamic analysis of the development of the Molecular Diagnostics industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Market Data Breakdown by Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some prominent players in the market includes:
F. Hoffmann-La Roche Ltd(Switzerland)
Hologic, Inc., (U.S.)
bioMérieux (France)
Abbott (U.S.)
QIAGEN (Netherlands)
Thermo Fisher Scientific (U.S.)
Siemens (Germany)
Danaher (U.S.)
Myriad Genetics Inc. (U.S.)
Illumina Inc. (U.S.)
Agilent Technologies Inc. (U.S.)
BD (U.S), DiaSorin S.p.A (Italy)
Grifols S.A. (Spain)
Quidel Corporation(U.S.)
Genetic Signatures (Australia)
MDxHealth, Inc. (U.S.)
Exact Sciences Corporation (U.S.)
Biocartis (Belgium)
TBG Diagnostics Limited (Australia)
GenMark Diagnostics Inc. (U.S.)
Luminex Corporation (U.S.)
HTG Molecular Diagnostics Inc. (U.S.)
Vela Diagnostics (Singapore)
Amoy Diagnostics Co., Ltd. (China)
Molbio Diagnostics Pvt. Ltd. (India)
geneOmbio (India)
Market Data Breakdown by Type
Reagents and Kits
Instruments
Services and Software
Market Data Breakdown by Applications
Hospital
Clinical Laboratories
Academics
Table of Content
1 Molecular Diagnostics Market Introduction and Overview
1.1 Molecular Diagnostics Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Molecular Diagnostics Industry Dynamic Analysis
1.5.1 Molecular Diagnostics Market Trends Analysis
1.5.2 Molecular Diagnostics Market Drivers Analysis
1.5.3 Molecular Diagnostics Market Challenges Analysis
1.5.4 Molecular Diagnostics Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Molecular Diagnostics Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Molecular Diagnostics Revenue and Share by Type
3 Global Molecular Diagnostics Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Molecular Diagnostics Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Molecular Diagnostics Market Size (2018-2023)
4.2 Molecular Diagnostics Growth Insights by Regions
4.2.1 Molecular Diagnostics Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Molecular Diagnostics Revenue Market Size by Regions (2018-2023)
4.2.3 North America Molecular Diagnostics Market Size (2018-2023)
4.2.4 Europe Molecular Diagnostics Market Size (2018-2023)
4.2.5 Asia-Pacific Molecular Diagnostics Market Size (2018-2023)
4.2.6 Latin America Molecular Diagnostics Market Size (2018-2023)
4.2.7 Middle East & Africa Molecular Diagnostics Market Size (2018-2023)
5 North America
5.1 North America Molecular Diagnostics Revenue by Countries
5.1.1 North America Molecular Diagnostics Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Molecular Diagnostics Revenue by Countries
6.1.1 Asia Pacific Molecular Diagnostics Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Molecular Diagnostics Revenue by Countries
7.1.1 Europe Molecular Diagnostics Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Molecular Diagnostics Revenue by Countries
8.1.1 Latin America Molecular Diagnostics Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Molecular Diagnostics Revenue by Countries
9.1.1 Middle East & Africa Molecular Diagnostics Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Molecular Diagnostics Market Competition, by Players
10.1 Global Molecular Diagnostics Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Molecular Diagnostics Players Market Share in 2022
10.2.2 Top 6 Molecular Diagnostics Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Molecular Diagnostics Players Head Office, Business Provided
10.4 Molecular Diagnostics Mergers & Acquisitions
10.5 Molecular Diagnostics New Entrants and Expansion Plans
11 Players Profiles
11.1 F. Hoffmann-La Roche Ltd(Switzerland)
11.1.1 F. Hoffmann-La Roche Ltd(Switzerland) Company Profile
11.1.2 Molecular Diagnostics Product Overview
11.1.3 F. Hoffmann-La Roche Ltd(Switzerland) Molecular Diagnostics Market Performance (2018-2023)
11.1.4 F. Hoffmann-La Roche Ltd(Switzerland) Business Overview
11.1.5 Recent Developments and Plans
11.2 Hologic, Inc., (U.S.)
11.2.1 Hologic, Inc., (U.S.) Company Profile
11.2.2 Molecular Diagnostics Product Overview
11.2.3 Hologic, Inc., (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.2.4 Hologic, Inc., (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 bioMérieux (France)
11.3.1 bioMérieux (France) Company Profile
11.3.2 Molecular Diagnostics Product Overview
11.3.3 bioMérieux (France) Molecular Diagnostics Market Performance (2018-2023)
11.3.4 bioMérieux (France) Business Overview
11.3.5 Recent Developments and Plans
11.4 Abbott (U.S.)
11.4.1 Abbott (U.S.) Company Profile
11.4.2 Molecular Diagnostics Product Overview
11.4.3 Abbott (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.4.4 Abbott (U.S.) Business Overview
11.4.5 Recent Developments and Plans
11.5 QIAGEN (Netherlands)
11.5.1 QIAGEN (Netherlands) Company Profile
11.5.2 Molecular Diagnostics Product Overview
11.5.3 QIAGEN (Netherlands) Molecular Diagnostics Market Performance (2018-2023)
11.5.4 QIAGEN (Netherlands) Business Overview
11.5.5 Recent Developments and Plans
11.6 Thermo Fisher Scientific (U.S.)
11.6.1 Thermo Fisher Scientific (U.S.) Company Profile
11.6.2 Molecular Diagnostics Product Overview
11.6.3 Thermo Fisher Scientific (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.6.4 Thermo Fisher Scientific (U.S.) Business Overview
11.6.5 Recent Developments and Plans
11.7 Siemens (Germany)
11.7.1 Siemens (Germany) Company Profile
11.7.2 Molecular Diagnostics Product Overview
11.7.3 Siemens (Germany) Molecular Diagnostics Market Performance (2018-2023)
11.7.4 Siemens (Germany) Business Overview
11.7.5 Recent Developments and Plans
11.8 Danaher (U.S.)
11.8.1 Danaher (U.S.) Company Profile
11.8.2 Molecular Diagnostics Product Overview
11.8.3 Danaher (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.8.4 Danaher (U.S.) Business Overview
11.8.5 Recent Developments and Plans
11.9 Myriad Genetics Inc. (U.S.)
11.9.1 Myriad Genetics Inc. (U.S.) Company Profile
11.9.2 Molecular Diagnostics Product Overview
11.9.3 Myriad Genetics Inc. (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.9.4 Myriad Genetics Inc. (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Illumina Inc. (U.S.)
11.10.1 Illumina Inc. (U.S.) Company Profile
11.10.2 Molecular Diagnostics Product Overview
11.10.3 Illumina Inc. (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.10.4 Illumina Inc. (U.S.) Business Overview
11.10.5 Recent Developments and Plans
11.11 Agilent Technologies Inc. (U.S.)
11.11.1 Agilent Technologies Inc. (U.S.) Company Profile
11.11.2 Molecular Diagnostics Product Overview
11.11.3 Agilent Technologies Inc. (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.11.4 Agilent Technologies Inc. (U.S.) Business Overview
11.11.5 Recent Developments and Plans
11.12 BD (U.S), DiaSorin S.p.A (Italy)
11.12.1 BD (U.S), DiaSorin S.p.A (Italy) Company Profile
11.12.2 Molecular Diagnostics Product Overview
11.12.3 BD (U.S), DiaSorin S.p.A (Italy) Molecular Diagnostics Market Performance (2018-2023)
11.12.4 BD (U.S), DiaSorin S.p.A (Italy) Business Overview
11.12.5 Recent Developments and Plans
11.13 Grifols S.A. (Spain)
11.13.1 Grifols S.A. (Spain) Company Profile
11.13.2 Molecular Diagnostics Product Overview
11.13.3 Grifols S.A. (Spain) Molecular Diagnostics Market Performance (2018-2023)
11.13.4 Grifols S.A. (Spain) Business Overview
11.13.5 Recent Developments and Plans
11.14 Quidel Corporation(U.S.)
11.14.1 Quidel Corporation(U.S.) Company Profile
11.14.2 Molecular Diagnostics Product Overview
11.14.3 Quidel Corporation(U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.14.4 Quidel Corporation(U.S.) Business Overview
11.14.5 Recent Developments and Plans
11.15 Genetic Signatures (Australia)
11.15.1 Genetic Signatures (Australia) Company Profile
11.15.2 Molecular Diagnostics Product Overview
11.15.3 Genetic Signatures (Australia) Molecular Diagnostics Market Performance (2018-2023)
11.15.4 Genetic Signatures (Australia) Business Overview
11.15.5 Recent Developments and Plans
11.16 MDxHealth, Inc. (U.S.)
11.16.1 MDxHealth, Inc. (U.S.) Company Profile
11.16.2 Molecular Diagnostics Product Overview
11.16.3 MDxHealth, Inc. (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.16.4 MDxHealth, Inc. (U.S.) Business Overview
11.16.5 Recent Developments and Plans
11.17 Exact Sciences Corporation (U.S.)
11.17.1 Exact Sciences Corporation (U.S.) Company Profile
11.17.2 Molecular Diagnostics Product Overview
11.17.3 Exact Sciences Corporation (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.17.4 Exact Sciences Corporation (U.S.) Business Overview
11.17.5 Recent Developments and Plans
11.18 Biocartis (Belgium)
11.18.1 Biocartis (Belgium) Company Profile
11.18.2 Molecular Diagnostics Product Overview
11.18.3 Biocartis (Belgium) Molecular Diagnostics Market Performance (2018-2023)
11.18.4 Biocartis (Belgium) Business Overview
11.18.5 Recent Developments and Plans
11.19 TBG Diagnostics Limited (Australia)
11.19.1 TBG Diagnostics Limited (Australia) Company Profile
11.19.2 Molecular Diagnostics Product Overview
11.19.3 TBG Diagnostics Limited (Australia) Molecular Diagnostics Market Performance (2018-2023)
11.19.4 TBG Diagnostics Limited (Australia) Business Overview
11.19.5 Recent Developments and Plans
11.20 GenMark Diagnostics Inc. (U.S.)
11.20.1 GenMark Diagnostics Inc. (U.S.) Company Profile
11.20.2 Molecular Diagnostics Product Overview
11.20.3 GenMark Diagnostics Inc. (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.20.4 GenMark Diagnostics Inc. (U.S.) Business Overview
11.20.5 Recent Developments and Plans
11.21 Luminex Corporation (U.S.)
11.21.1 Luminex Corporation (U.S.) Company Profile
11.21.2 Molecular Diagnostics Product Overview
11.21.3 Luminex Corporation (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.21.4 Luminex Corporation (U.S.) Business Overview
11.21.5 Recent Developments and Plans
11.22 HTG Molecular Diagnostics Inc. (U.S.)
11.22.1 HTG Molecular Diagnostics Inc. (U.S.) Company Profile
11.22.2 Molecular Diagnostics Product Overview
11.22.3 HTG Molecular Diagnostics Inc. (U.S.) Molecular Diagnostics Market Performance (2018-2023)
11.22.4 HTG Molecular Diagnostics Inc. (U.S.) Business Overview
11.22.5 Recent Developments and Plans
11.23 Vela Diagnostics (Singapore)
11.23.1 Vela Diagnostics (Singapore) Company Profile
11.23.2 Molecular Diagnostics Product Overview
11.23.3 Vela Diagnostics (Singapore) Molecular Diagnostics Market Performance (2018-2023)
11.23.4 Vela Diagnostics (Singapore) Business Overview
11.23.5 Recent Developments and Plans
11.24 Amoy Diagnostics Co., Ltd. (China)
11.24.1 Amoy Diagnostics Co., Ltd. (China) Company Profile
11.24.2 Molecular Diagnostics Product Overview
11.24.3 Amoy Diagnostics Co., Ltd. (China) Molecular Diagnostics Market Performance (2018-2023)
11.24.4 Amoy Diagnostics Co., Ltd. (China) Business Overview
11.24.5 Recent Developments and Plans
11.25 Molbio Diagnostics Pvt. Ltd. (India)
11.25.1 Molbio Diagnostics Pvt. Ltd. (India) Company Profile
11.25.2 Molecular Diagnostics Product Overview
11.25.3 Molbio Diagnostics Pvt. Ltd. (India) Molecular Diagnostics Market Performance (2018-2023)
11.25.4 Molbio Diagnostics Pvt. Ltd. (India) Business Overview
11.25.5 Recent Developments and Plans
11.26 geneOmbio (India)
11.26.1 geneOmbio (India) Company Profile
11.26.2 Molecular Diagnostics Product Overview
11.26.3 geneOmbio (India) Molecular Diagnostics Market Performance (2018-2023)
11.26.4 geneOmbio (India) Business Overview
11.26.5 Recent Developments and Plans
12 Global Molecular Diagnostics Forecast Market Insights by Type
12.1 Global Molecular Diagnostics Revenue Market Forecast by Type (2023-2029)
13 Global Molecular Diagnostics Forecast Market Insights by Application
13.1 Molecular Diagnostics Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Molecular Diagnostics Forecast Market Size (2023-2029)
14.2 Molecular Diagnostics Growth Forecast Insights by Regions
14.2.1 Molecular Diagnostics Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Molecular Diagnostics Forecast Market Size (2023-2029)
14.2.3 Europe Molecular Diagnostics Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Molecular Diagnostics Forecast Market Size (2023-2029)
14.2.5 Latin America Molecular Diagnostics Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Molecular Diagnostics Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer
List of Tables and Figures
Figure Molecular Diagnostics Picture
Table Product Definition of Molecular Diagnostics
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Molecular Diagnostics Market Size by Type (2018 VS 2023 VS 2029)
Table Global Molecular Diagnostics Revenue by Type (2018-2023)
Table Global Molecular Diagnostics Revenue and Share by Type (2018-2023)
Table Global Molecular Diagnostics Market Size by Application (2018 VS 2023 VS 2029)
Table Global Molecular Diagnostics Revenue by Application (2018-2023)
Table Global Molecular Diagnostics Revenue Share by Application (2018-2023)
Figure Global Molecular Diagnostics Revenue Market Size Growth (2018-2023)
Table Molecular Diagnostics Market Size by Regions: 2018 VS 2023 VS 2029
Table Molecular Diagnostics Revenue Market Size by Regions (2018-2023)
Table Molecular Diagnostics Revenue and Share by Regions (2018-2023)
Figure North America Molecular Diagnostics Market Size (2018-2023)
Figure Europe Molecular Diagnostics Market Size (2018-2023)
Figure Asia-Pacific Molecular Diagnostics Market Size (2018-2023)
Figure Latin America Molecular Diagnostics Market Size (2018-2023)
Figure Middle East & Africa Molecular Diagnostics Market Size (2018-2023)
Table North America Molecular Diagnostics Revenue by Countries (2018-2023)
Table North America Molecular Diagnostics Revenue and Share by Countries (2018-2023)
Table North America PEST Analysis
Figure United States Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Canada Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Canada Molecular Diagnostics Sales and Growth (2018-2023)
Table Asia-Pacific Molecular Diagnostics Revenue by Countries (2018-2023)
Table Asia-Pacific Molecular Diagnostics Revenue and Share by Countries (2018-2023)
Table Asia-Pacific PEST Analysis
Figure China Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Japan Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Korea Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Southeast Asia Molecular Diagnostics Revenue and Growth (2018-2023)
Figure India Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Australia Molecular Diagnostics Revenue and Growth (2018-2023)
Table Europe Molecular Diagnostics Revenue by Countries (2018-2023)
Table Europe Molecular Diagnostics Revenue and Share by Countries (2018-2023)
Table Europe PEST Analysis
Figure Germany Molecular Diagnostics Revenue and Growth (2018-2023)
Figure France Molecular Diagnostics Revenue and Growth (2018-2023)
Figure UK Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Italy Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Russia Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Spain Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Nordic Molecular Diagnostics Revenue and Growth (2018-2023)
Table Latin America Molecular Diagnostics Revenue by Countries (2018-2023)
Table Latin America Molecular Diagnostics Revenue and Share by Countries (2018-2023)
Table Latin America PEST Analysis
Figure Brazil Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Argentina Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Mexico Molecular Diagnostics Revenue and Growth (2018-2023)
Table Middle East & Africa Molecular Diagnostics Revenue by Countries (2018-2023)
Table Middle East & Africa Molecular Diagnostics Revenue and Share by Countries (2018-2023)
Table Middle East & Africa PEST Analysis
Figure Egypt Molecular Diagnostics Revenue and Growth (2018-2023)
Figure South Africa Molecular Diagnostics Revenue and Growth (2018-2023)
Figure UAE Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Turkey Molecular Diagnostics Revenue and Growth (2018-2023)
Figure Saudi Arabia Molecular Diagnostics Revenue and Growth (2018-2023)
Table Global Molecular Diagnostics Revenue by Players (2018-2023)
Table Global Molecular Diagnostics Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Molecular Diagnostics Players Market Concentration Ratio (CR5) (2018-2023)
Table Molecular Diagnostics Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table F. Hoffmann-La Roche Ltd(Switzerland) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd(Switzerland) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd(Switzerland) Revenue and Growth Rate
Figure F. Hoffmann-La Roche Ltd(Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Hologic, Inc., (U.S.) Profile
Table Product Overview
Table Hologic, Inc., (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Hologic, Inc., (U.S.) Revenue and Growth Rate
Figure Hologic, Inc., (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table bioMérieux (France) Profile
Table Product Overview
Table bioMérieux (France) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure bioMérieux (France) Revenue and Growth Rate
Figure bioMérieux (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Abbott (U.S.) Profile
Table Product Overview
Table Abbott (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Abbott (U.S.) Revenue and Growth Rate
Figure Abbott (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table QIAGEN (Netherlands) Profile
Table Product Overview
Table QIAGEN (Netherlands) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure QIAGEN (Netherlands) Revenue and Growth Rate
Figure QIAGEN (Netherlands) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Thermo Fisher Scientific (U.S.) Profile
Table Product Overview
Table Thermo Fisher Scientific (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Thermo Fisher Scientific (U.S.) Revenue and Growth Rate
Figure Thermo Fisher Scientific (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Siemens (Germany) Profile
Table Product Overview
Table Siemens (Germany) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Siemens (Germany) Revenue and Growth Rate
Figure Siemens (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Danaher (U.S.) Profile
Table Product Overview
Table Danaher (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Danaher (U.S.) Revenue and Growth Rate
Figure Danaher (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Myriad Genetics Inc. (U.S.) Profile
Table Product Overview
Table Myriad Genetics Inc. (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Myriad Genetics Inc. (U.S.) Revenue and Growth Rate
Figure Myriad Genetics Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Illumina Inc. (U.S.) Profile
Table Product Overview
Table Illumina Inc. (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Illumina Inc. (U.S.) Revenue and Growth Rate
Figure Illumina Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Agilent Technologies Inc. (U.S.) Profile
Table Product Overview
Table Agilent Technologies Inc. (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Agilent Technologies Inc. (U.S.) Revenue and Growth Rate
Figure Agilent Technologies Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table BD (U.S), DiaSorin S.p.A (Italy) Profile
Table Product Overview
Table BD (U.S), DiaSorin S.p.A (Italy) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure BD (U.S), DiaSorin S.p.A (Italy) Revenue and Growth Rate
Figure BD (U.S), DiaSorin S.p.A (Italy) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Grifols S.A. (Spain) Profile
Table Product Overview
Table Grifols S.A. (Spain) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Grifols S.A. (Spain) Revenue and Growth Rate
Figure Grifols S.A. (Spain) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Quidel Corporation(U.S.) Profile
Table Product Overview
Table Quidel Corporation(U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Quidel Corporation(U.S.) Revenue and Growth Rate
Figure Quidel Corporation(U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Genetic Signatures (Australia) Profile
Table Product Overview
Table Genetic Signatures (Australia) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Genetic Signatures (Australia) Revenue and Growth Rate
Figure Genetic Signatures (Australia) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table MDxHealth, Inc. (U.S.) Profile
Table Product Overview
Table MDxHealth, Inc. (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure MDxHealth, Inc. (U.S.) Revenue and Growth Rate
Figure MDxHealth, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Exact Sciences Corporation (U.S.) Profile
Table Product Overview
Table Exact Sciences Corporation (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Exact Sciences Corporation (U.S.) Revenue and Growth Rate
Figure Exact Sciences Corporation (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Biocartis (Belgium) Profile
Table Product Overview
Table Biocartis (Belgium) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Biocartis (Belgium) Revenue and Growth Rate
Figure Biocartis (Belgium) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table TBG Diagnostics Limited (Australia) Profile
Table Product Overview
Table TBG Diagnostics Limited (Australia) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure TBG Diagnostics Limited (Australia) Revenue and Growth Rate
Figure TBG Diagnostics Limited (Australia) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table GenMark Diagnostics Inc. (U.S.) Profile
Table Product Overview
Table GenMark Diagnostics Inc. (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure GenMark Diagnostics Inc. (U.S.) Revenue and Growth Rate
Figure GenMark Diagnostics Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Luminex Corporation (U.S.) Profile
Table Product Overview
Table Luminex Corporation (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Luminex Corporation (U.S.) Revenue and Growth Rate
Figure Luminex Corporation (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table HTG Molecular Diagnostics Inc. (U.S.) Profile
Table Product Overview
Table HTG Molecular Diagnostics Inc. (U.S.) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure HTG Molecular Diagnostics Inc. (U.S.) Revenue and Growth Rate
Figure HTG Molecular Diagnostics Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Vela Diagnostics (Singapore) Profile
Table Product Overview
Table Vela Diagnostics (Singapore) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Vela Diagnostics (Singapore) Revenue and Growth Rate
Figure Vela Diagnostics (Singapore) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Amoy Diagnostics Co., Ltd. (China) Profile
Table Product Overview
Table Amoy Diagnostics Co., Ltd. (China) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Amoy Diagnostics Co., Ltd. (China) Revenue and Growth Rate
Figure Amoy Diagnostics Co., Ltd. (China) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Molbio Diagnostics Pvt. Ltd. (India) Profile
Table Product Overview
Table Molbio Diagnostics Pvt. Ltd. (India) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Molbio Diagnostics Pvt. Ltd. (India) Revenue and Growth Rate
Figure Molbio Diagnostics Pvt. Ltd. (India) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table geneOmbio (India) Profile
Table Product Overview
Table geneOmbio (India) Molecular Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure geneOmbio (India) Revenue and Growth Rate
Figure geneOmbio (India) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Molecular Diagnostics Revenue Forecast by Type (2023-2029)
Table Global Molecular Diagnostics Revenue and Share Forecast by Type (2023-2029)
Table Global Molecular Diagnostics Revenue by Application (2023-2029)
Table Global Molecular Diagnostics Revenue and Share by Application (2023-2029)
Figure Global Molecular Diagnostics Revenue Forecast Market Size (2023-2029)
Table Molecular Diagnostics Revenue Forecast by Regions (2023-2029)
Table Molecular Diagnostics Revenue and Share Forecast by Regions (2023-2029)
Figure North America Molecular Diagnostics Revenue Forecast Market Size (2023-2029)
Figure Europe Molecular Diagnostics Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Molecular Diagnostics Revenue Forecast Market Size (2023-2029)
Figure Latin America Molecular Diagnostics Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Molecular Diagnostics Revenue Forecast Market Size (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|